Todd Shearer

972 total citations
30 papers, 485 citations indexed

About

Todd Shearer is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Todd Shearer has authored 30 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Todd Shearer's work include Glioma Diagnosis and Treatment (4 papers), Muscle metabolism and nutrition (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Todd Shearer is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Muscle metabolism and nutrition (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Todd Shearer collaborates with scholars based in United States, Spain and Australia. Todd Shearer's co-authors include Craig E. Crosson, Marc K. Hellerstein, Stephen A. Stimpson, William J. Evans, Lisa G. Clifton, Scott Turner, Katja Remlinger, Barry G. Shearer, John C. Ulrich and Michael R. Jeune and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Todd Shearer

28 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Shearer United States 12 198 135 73 68 49 30 485
Simon Cheung Canada 13 309 1.6× 208 1.5× 70 1.0× 17 0.3× 36 0.7× 21 756
Sonia Brault Canada 10 282 1.4× 95 0.7× 67 0.9× 69 1.0× 27 0.6× 11 535
Anne Marilise Marrache Canada 11 361 1.8× 137 1.0× 74 1.0× 54 0.8× 36 0.7× 16 740
Tongju Guan United States 11 319 1.6× 83 0.6× 49 0.7× 45 0.7× 34 0.7× 19 571
Karen Aughton United Kingdom 10 215 1.1× 44 0.3× 31 0.4× 33 0.5× 39 0.8× 15 397
D. Demolle Belgium 11 295 1.5× 185 1.4× 29 0.4× 37 0.5× 27 0.6× 23 506
Albino Bonazzi Italy 13 191 1.0× 163 1.2× 11 0.2× 48 0.7× 60 1.2× 21 637
Jennifer Duplantier United States 9 369 1.9× 24 0.2× 29 0.4× 70 1.0× 34 0.7× 9 575
Erin Conboy United States 11 241 1.2× 164 1.2× 27 0.4× 118 1.7× 32 0.7× 28 481

Countries citing papers authored by Todd Shearer

Since Specialization
Citations

This map shows the geographic impact of Todd Shearer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Shearer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Shearer more than expected).

Fields of papers citing papers by Todd Shearer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Shearer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Shearer. The network helps show where Todd Shearer may publish in the future.

Co-authorship network of co-authors of Todd Shearer

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Shearer. A scholar is included among the top collaborators of Todd Shearer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Shearer. Todd Shearer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Robinson, Giles, Anna Vinitsky, Asim K. Bag, et al.. (2024). CTNI-70. RESULTS FROM THE PHASE 1 AND PHASE 1 EXPANSION COHORTS OF SJ901: A PHASE 1/2 TRIAL OF SINGLE-AGENT MIRDAMETINIB (PD-0325901) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOW-GRADE GLIOMA. Neuro-Oncology. 26(Supplement_8). viii113–viii113. 1 indexed citations
3.
Shearer, Todd, Mark C. Johnson, Ewa Cendrowicz, et al.. (2024). Kinetics of Nirogacestat-Mediated Increases in B-cell Maturation Antigen on Plasma Cells Inform Therapeutic Combinations in Multiple Myeloma. Cancer Research Communications. 4(12). 3114–3123.
4.
Melero, Ignacio, Judy S. Wang, Martin Gutierrez, et al.. (2024). Cln-619 (anti-MICA/B antibody) alone and in combination with pembrolizumab (P) for advanced solid tumors: Updated results of a Ph1 study.. Journal of Clinical Oncology. 42(16_suppl). 2588–2588. 1 indexed citations
5.
Heitmann, Jonas S., Juliane S. Walz, Helmut R. Salih, et al.. (2024). A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study of Cln-049 for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease. Blood. 144(Supplement 1). 2883.1–2883.1. 1 indexed citations
6.
Konstantinopoulos, Panagiotis A., et al.. (2023). Trial in progress: A phase two trial of nirogacestat, a gamma-secretase inhibitor, in patients with recurrent ovarian granulosa cell tumors (NCT05348356) (1284). Gynecologic Oncology. 176. S177–S178. 2 indexed citations
7.
Shearer, Todd, Mark P. Johnson, Ewa Cendrowicz, et al.. (2023). Population pharmacokinetic-pharmacodynamic model of nirogacestat effects on B-cell maturation antigen in healthy subjects.. Journal of Clinical Oncology. 41(16_suppl). 8027–8027. 2 indexed citations
8.
9.
McCully, Cynthia Lester, Todd Shearer, Andrea M. Gross, et al.. (2022). EXTH-102. PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS (PK) OF MIRDAMETINIB IN A NON-HUMAN PRIMATE (NHP) MODEL. Neuro-Oncology. 24(Supplement_7). vii233–vii233. 1 indexed citations
10.
Lewis, James H., Paul Cottu, Todd Shearer, et al.. (2020). Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity. Drug Safety. 43(10). 1045–1055. 11 indexed citations
11.
Zhang, Xinwen, Rong Du, Wei Min, et al.. (2020). Abstract 6415: RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors. Cancer Research. 80(16_Supplement). 6415–6415. 4 indexed citations
12.
Muntendam, Pieter, et al.. (2016). Pharmacokinetic Response after Subcutaneous Administration of Ceftriaxone.. Open Forum Infectious Diseases. 3(suppl_1). 5 indexed citations
13.
Stimpson, Stephen A., Michael S. Leonard, Lisa G. Clifton, et al.. (2013). Longitudinal determination of total body creatine pool size and skeletal muscle mass in rats by D 3 ‐creatine dilution. The FASEB Journal. 27(S1). 1 indexed citations
14.
Stimpson, Stephen A., Scott Turner, Lisa G. Clifton, et al.. (2012). Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-d3) dilution in rats. Journal of Applied Physiology. 112(11). 1940–1948. 55 indexed citations
15.
Ignar, Diane M., Aaron S. Goetz, Joyce A. Boucheron, et al.. (2011). Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 339(1). 24–34. 41 indexed citations
16.
Kozar, Michael P., Kirsten S. Smith, Jason Sousa, et al.. (2007). Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Drug Metabolism and Disposition. 36(2). 380–385. 10 indexed citations
17.
Li, Qigui, Michael P. Kozar, Todd Shearer, et al.. (2007). Pharmacokinetics, Safety, and Hydrolysis of Oral Pyrroloquinazolinediamines Administered in Single and Multiple Doses in Rats. Antimicrobial Agents and Chemotherapy. 51(8). 2898–2904. 3 indexed citations
18.
Shearer, Todd, Michael P. Kozar, Michael T. O’Neil, et al.. (2005). In Vitro Metabolism of Phenoxypropoxybiguanide Analogues in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Journal of Medicinal Chemistry. 48(8). 2805–2813. 19 indexed citations
19.
Webb, Jerry G., et al.. (2003). Bradykinin enhancement of PGE2 signalling in bovine trabecular meshwork cells. Experimental Eye Research. 76(3). 283–289. 14 indexed citations
20.
Shearer, Todd & Craig E. Crosson. (2001). Activation of Extracellular Signal-regulated Kinase in Trabecular Meshwork Cells. Experimental Eye Research. 73(1). 25–35. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Cheung Breakdown of academic impact, for papers by Sonia Brault Breakdown of academic impact, for papers by Anne Marilise Marrache Breakdown of academic impact, for papers by Tongju Guan Breakdown of academic impact, for papers by Karen Aughton Breakdown of academic impact, for papers by D. Demolle Breakdown of academic impact, for papers by Albino Bonazzi Breakdown of academic impact, for papers by Jennifer Duplantier Breakdown of academic impact, for papers by Erin Conboy
Rankless by CCL
2026